Andersons pediatric cardiology 1685
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.77 KB, 3 trang )
restrictivecardiomyopathyinchildreniscaused
bymutationsincardiacsarcomereproteingenes.
Heart.2008;94(11):1478–1484.
355.BrodehlA,FerrierRA,HamiltonSJ,etal.
MutationsinFLNCareassociatedwithfamilial
restrictivecardiomyopathy.HumMutat.
2016;37(3):269–279.
356.KostarevaA,KiselevA,GudkovaA,etal.
Geneticspectrumofidiopathicrestrictive
cardiomyopathyuncoveredbyNext-generation
sequencing.PLoSONE.2016;11(9):e0163362.
357.MocumbiAO,FerreiraMB,SidiD,YacoubMH.
Apopulationstudyofendomyocardialfibrosisin
aruralareaofMozambique.NEnglJMed.
2008;359(1):43–49.
358.D'ArbelaPG,MutazindwaT,PatelAK,Somers
K.Survivalafterfirstpresentationwith
endomyocardialfibrosis.BrHeartJ.
1972;34(4):403–407.
359.GrimaldiA,MocumbiAO,FreersJ,etal.
Tropicalendomyocardialfibrosis:natural
history,Challenges,andperspectives.
Circulation.2016;133(24):2503–2515.
360.OmmenSR,SewardJB,TajikAJ.Clinicaland
echocardiographicfeaturesofhypereosinophilic
syndromes.AmJCardiol.2000;86(1):110–113.
361.ZhouY,LowerEE,LiHP,etal.Cardiac
sarcoidosis:theimpactofageandimplanted
devicesonsurvival.Chest.2017;151(1):139–
148.
362.KandolinR,LehtonenJ,AiraksinenJ,etal.
Cardiacsarcoidosis:epidemiology,
characteristics,andoutcomeover25yearsina
nationwidestudy.Circulation.2015;131(7):624–
632.
363.HultenE,AgarwalV,CahillM,etal.Presenceof
lategadoliniumenhancementbycardiac
magneticresonanceamongpatientswith
suspectedcardiacsarcoidosisisassociatedwith
adversecardiovascularprognosis:Asystematic
reviewandMeta-analysis.CircCardiovasc
Imaging.2016;9(9):e005001.
364.GertzMA,BensonMD,DyckPJ,etal.
Diagnosis,Prognosis,andtherapyof
transthyretinamyloidosis.JAmCollCardiol.
2015;66(21):2451–2466.
365.SiegelRJ,ShahPK,FishbeinMC.Idiopathic
restrictivecardiomyopathy.Circulation.
1984;70(2):165–169.
366.WalshMA,GrenierMA,JefferiesJL,etal.
Conductionabnormalitiesinpediatricpatients
withrestrictivecardiomyopathy.CircHeart
Fail.2012;5(2):267–273.
367.El-AssaadI,Al-KindiSG,OliveiraGH,Boyle
GJ,AzizPF.Implantablecardioverterdefibrillatorandwait-listoutcomesinpediatric
patientsawaitinghearttransplantation.Heart
Rhythm.2015;12(12):2443–2448.
368.Sen-ChowdhryS,SyrrisP,WardD,etal.
Clinicalandgeneticcharacterizationoffamilies
witharrhythmogenicrightventricular
dysplasia/cardiomyopathyprovidesnovel
insightsintopatternsofdiseaseexpression.
Circulation.2007;115(13):1710–1720.
369.PetersS,TrummelM,MeynersW.Prevalenceof
rightventriculardysplasia-cardiomyopathyina
non-referralhospital.IntJCardiol.
2004;97(3):499–501.
370.DalalD,JamesC,DevanagondiR,etal.
Penetranceofmutationsinplakophilin-2among
familieswitharrhythmogenicrightventricular
dysplasia/cardiomyopathy.JAmCollCardiol.
2006;48(7):1416–1424.
371.QuartaG,MuirA,PantazisA,etal.Familial
evaluationinarrhythmogenicrightventricular
cardiomyopathy:impactofgeneticsandrevised
taskforcecriteria.Circulation.
2011;123(23):2701–2709.
372.FinocchiaroG,PapadakisM,RobertusJL,etal.
Etiologyofsuddendeathinsports:insightsfrom
aUnitedKingdomregionalregistry.JAmColl
